See what Abbott, Medtronic, and Boston Scientific were up to this time last year.

Katie Hobbins, Managing Editor

January 5, 2023

1 Min Read
calendar (1).jpg
Image courtesy of Brian Jackson / Alamy Stock Photo

Quidel's Diagnostic Success Pays Off with Major M&A

Quidel has entered into an agreement to acquire Ortho Clinical Diagnostics Holdings for $6 billion.

Hospital Staffing Shortages and Omicron Disrupt Elective Surgery

Rising COVID hospitalizations and hospital staffing shortages are once again expected to force elective procedures to the back burner.

Reducing Maternal and Newborn Deaths in Kenya through Medtech

Proximie’s platform will enable surgeons to 'virtually transport' into any operating room in the world to visually interact with and guide surgeons.

Tackling Tuberculosis in Children through Non-Invasive Sampling

42 Technology partnered with FIND and Rutgers University to develop a solution for diagnosing tuberculosis in children.

2 Medtech Giants Are Working to Enhance Cardiac Care in Southeast Asia

Boston Scientific and GE Healthcare are bringing their interventional cardiology portfolios to cardiac care centers.

Life After Tiara: Neovasc Rebounds with Progress on Reducer

Neovasc enrolled the first patient in a pivotal trial of a device that reduces angina symptoms in patients with refractory angina.

Emerging Markets Are a Missed Opportunity for Medical Device OEMs

An industry thought leader says medical device manufacturers often fail to fully realize commercial opportunities in emerging markets.

Abbott Unveils New Biowearables Category During Historic CES Keynote

Abbott's new consumer biowearables technology will track key biomarkers in the body such as glucose, ketones, lactate, and alcohol, to help consumers better understand their health and wellness.

Medtronic Recalls Synergy Cranial and Related Software Due to Glitch

Medtronic is recalling its Synergy Cranial and StealthStation S7 Cranial software due to the risk of potential inaccuracies.

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like